BIOMAT Database Logo BIOMAT Database Logo

[In vitro study of sensitivity of leukemic cells to cytotoxic drugs (anticytogram)]. 1975

R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser

The in vitro sensitivity of leukemic cells to cytotoxic drugs was assessed in 61 cases of acute leukemia in adults, 49 of them were of the no lymphoblastic type and in the first phase of the disease. The depression of the incorporation of 14-C-thymidine and 3-H-uridine after a two hours incubation with the various cytotoxic drugs was compared with the clinical result obtained with two of them There is a significant correlation between the in vitro depression of the incorporation of 14-C-thymidine and the clinical effect of the drugs. This method, which may be utilized also in solid tumors, allows to predict with some accuracy the effect of chemotherapy, and to select between the various cytotoxic drugs. However the failure of a chemotherapy is generally related to an in vitro insensitivity of the malignant cells to almost all drugs.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009002 Monomethylhydrazine Hydrazine substituted by one methyl group. Methylhydrazine
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C

Related Publications

R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells.
June 2004, Life sciences,
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
In vitro sensitivity of human leukemic cells to x-rays.
February 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs.
November 1985, American journal of hematology,
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.
January 1992, Cancer immunology, immunotherapy : CII,
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
In vitro test for sensitivity of leukemic cells to L-asparaginase.
May 1971, Cancer research,
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro.
May 1982, Blood,
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
A statistical model for in-vitro assessment of patient sensitivity to cytotoxic drugs.
December 1991, Biometrics,
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugs.
January 1988, In vivo (Athens, Greece),
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
January 2005, Neoplasma,
R Zittoun, and M Bouchard, and J Facquet-Danis, and C Diaz-Mayo, and M Percie-du-Sert, and J Bousser
In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.
December 1980, International journal of cancer,
Copied contents to your clipboard!